Cellceutix Corporation (CTIX)
Create an AlertCTIX Key Stats
| Income Statement | |
| Revenue TTM | 0.00 |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -0.0378 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -3.090M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 172.33M |
| Enterprise Value | 174.13M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | |
| Free Cash Flow | -0.2292M |
| Return on Equity | |
CTIX News
- CELLCEUTIX CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountan... Jun 5
- InPlay: Cellceutix Presents poster at ASCO on its clinical trial of anti-cancer ... Jun 3
- Cellceutix Presents Poster at ASCO on Its Clinical Trial of Anti-Cancer Drug Kev... Jun 3
- As Pfizer Eyes It, Celgene Calls Cellceutix May 31
- Cellceutix to Present Poster on Novel Anti-Cancer Drug at Annual ASCO Meeting Marketwired May 28
- 3 Small Cap Cancer Stocks With Upcoming Catalysts May 20
- CELLCEUTIX CORP Files SEC form 10-Q, Quarterly Report May 20
- Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Arrived May 9
- Potential 200% Return With Cellceutix Apr 22
- Coach Jim Boeheim Putting Up His Best Defense Against Michigan... and Cancer Marketwire Apr 5
CTIX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cellceutix Corporation is up 148.6% over the last year vs S&P 500 Total Return up 25.82%, Synta Pharmaceuticals down 30.56%, and ARCA biopharma down 56.19%.
CTIX Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these CTIX related companies
Pro Ratings for CTIX
Pro Report PDF for CTIX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download CTIX Pro Report PDF
Pro Strategies Featuring CTIX
Did Cellceutix Corporation make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
CTIX Profile
Sector: Healthcare
Industry: Biotechnology
Other CTIX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CTIX | 1.79 | -0.01 | -0.56% | 172.33M |
